MyBody-X angle on MTHFR Test

The MTHFR test is often marketed as a key to personalized health, especially regarding variants C677T and A1298C. However, the scientific evidence is limited: while homozygous carriers of C677T (about 10% of the population) may have slightly elevated homocysteine levels, the effect on most health outcomes (cardiovascular, depression, cancer) is weak or not reproducible. Large GWAS show that MTHFR variants explain only a small fraction of homocysteine variance. The idea that supplementing with methylfolate or methylcobalamin can reduce risks is not supported by robust RCTs. Many commercial tests overstate clinical relevance and suggest a need for action that is medically unjustified. A more sensible approach is to check homocysteine via blood test if elevated, then investigate underlying causes (e.g., kidney function, thyroid, B12 deficiency) and supplement accordingly – regardless of genotype. MyBody-X should clearly communicate that MTHFR tests are primarily informative, not diagnostic. Caveat: No self-medication recommendation; consult a physician.